SB 705498: Clinical Trials

7 trials of SB 705498, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 terminated. 7 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 27Completed 6, Terminated 1

Follow SB 705498: new trials by email Literature Review of SB 705498 trials Research Report on SB 705498

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intranasal SB-705498 in Allergic Rhinitis (AR) Patients
SB-705498, FP, placebo - Rhinitis
Phase 2CompletedGlaxoSmithKline702011-04-142019-09-13
A Study to Investigate the Effect of SB-705498 on Chronic Cough
Placebo, SB-705498 - Rhinitis
Phase 2CompletedGlaxoSmithKline212011-04-012016-12-01
SB705498 Proof of Concept Chamber Challenge in Subjects With Non Allergic Rhinitis
SB-705498, Placebo - Rhinitis
Phase 2CompletedGlaxoSmithKline402010-12-012018-01-29
Intranasal SB-705498 in Non-allergic Rhinitis Patients
Placebo, SB-705498 - Rhinitis
Phase 2CompletedGlaxoSmithKline402009-12-012016-12-01
Sb-705498 Rectal Pain Study
SB-705498 - Irritable Colon
Phase 2TerminatedGlaxoSmithKline12007-01-262018-08-20
Use Of SB-705498 In The Acute Treatment Of Migraine
SB-705498 - Migraine, Acute
Phase 2CompletedGlaxoSmithKline702006-01-012009-05-18
SB-705498 Dental Pain Study After Tooth Extraction
SB705498 400 mg, SB705498 1000 mg, Placebo - Toothache
Phase 2CompletedGlaxoSmithKline1452005-12-072019-01-28

Conditions studied

Rhinitis (4)  ·  Acute Pain (1)  ·  Inflammation (1)  ·  Irritable Bowel Syndrome (1)  ·  Migraine Disorders (1)  ·  Toothache (1)

Sponsors

GlaxoSmithKline (7)

Countries

United Kingdom (4)  ·  Canada (2)  ·  Netherlands (2)  ·  Australia (1)  ·  Austria (1)  ·  Italy (1)  ·  South Korea (1)